Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures, and supplies in-vitro diagnostic medical devices. The company's product portfolio includes bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit, and FMLP ELISA kit. It offers expertise such as clinical research, chemistry, chronic obstructive pulmonary disease, diagnostic development and enzyme-free blood glucose, microbial physiology, peritoneal dialysis, and wound care research, among others. Mologic serves medical professionals and patients. The company partners with industry, universities, and government institutions to develop new solutions. Mologic is headquartered in Bedford, Bedfordshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Mologic Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Mologic Ltd Company Overview
Mologic Ltd Company Snapshot
Mologic Ltd Pipeline Products and Ongoing Clinical Trials Overview
Mologic Ltd – Pipeline Analysis Overview
Mologic Ltd - Key Facts
Mologic Ltd - Major Products and Services
Mologic Ltd Pipeline Products by Development Stage
Mologic Ltd Ongoing Clinical Trials by Trial Status
Mologic Ltd Pipeline Products Overview
ACuTEGA
ACuTEGA Product Overview
BVPro - Home Use
BVPro - Home Use Product Overview
BVThrush Combi
BVThrush Combi Product Overview
Dengue Fever Diagnostic Test - Professional Use
Dengue Fever Diagnostic Test - Professional Use Product Overview
Dentiplex
Dentiplex Product Overview
DENTiPLEX BL
DENTiPLEX BL Product Overview
Diagnostic Test - Ebola Virus
Diagnostic Test - Ebola Virus Product Overview
Diagnostic Test - Malaria
Diagnostic Test - Malaria Product Overview
Diagnostic Test - Measles
Diagnostic Test - Measles Product Overview
Diagnostic Test - Rubella
Diagnostic Test - Rubella Product Overview
Diagnostic Test - TB LAM
Diagnostic Test - TB LAM Product Overview
Diagnostic Test - TB LAM Clinical Trial
Diagnostic Test - Yellow Fever
Diagnostic Test - Yellow Fever Product Overview
HeadStart
HeadStart Product Overview
HeadsUp
HeadsUp Product Overview
Next Generation COVID-19 Antigen Test
Next Generation COVID-19 Antigen Test Product Overview
Point Of Care Test - Urinary Tract Infections
Point Of Care Test - Urinary Tract Infections Product Overview
Point-of Care Test - Sepsis
Point-of Care Test - Sepsis Product Overview
Point-Of-Care Test - COVID-19
Point-Of-Care Test - COVID-19 Product Overview
Rapid Antigen Test - COVID-19
Rapid Antigen Test - COVID-19 Product Overview
Rapid Diagnostic Test - HCV
Rapid Diagnostic Test - HCV Product Overview
Rapid Diagnostic Test - Onchocerciasis
Rapid Diagnostic Test - Onchocerciasis Product Overview
Rapid Diagnostic Test - Schistosomiasis
Rapid Diagnostic Test - Schistosomiasis Product Overview
RightStart
RightStart Product Overview
Second Generation Pan Fever Diagnostic Test
Second Generation Pan Fever Diagnostic Test Product Overview
Utriplex
Utriplex Product Overview
Mologic Ltd - Key Competitors
Mologic Ltd - Key Employees
Mologic Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Mologic Ltd, Recent Developments
Mar 21, 2023: Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance
Feb 24, 2023: US FDA grants EUA to the Mologic COVI-Go SARS-CoV-2 Ag Self-Test
Dec 13, 2021: Latest study verifies detection of Covios Ag lateral flow test to Omicron variant
May 13, 2021: Mologic partners with FINDdx for schistosomiasis rapid test
Apr 06, 2021: Mologic’s COVID-19 Rapid Antigen Self-Test selected by NIH for RADx Initiative funding
Mar 02, 2021: Omega Diagnostics Group : Contract with Screen4 for COVID-19 antibody laboratory-based testing service
Dec 24, 2020: Mologic CE Mark Rapid Antigen Test
Apr 27, 2020: Omega Diagnostics Group : CE-Mark of COVID-19 ELISA antibody test
Apr 24, 2020: Mologic launches manufacturing facility to boost access to COVID-19 rapid diagnostic tests
Apr 20, 2020: Omega Diagnostics Group: Material Transfer Agreement signed with Mologic Ltd COVID-19 antibody test